We arrived with four finalists in what, we must admit, is a bit of a ”mish-mash” of a category, but is essentially the engineering industries and their supply bases. None the less, the assessors believe they have identified a worthy winner.
Author: Alexandra Leonards
The Healthcare category produced four shortlisted finalists, although for reasons that are obscure, one fancied entry didn”t continue through the assessment procedure.
Teamwork can mean almost anything – who hasn”t been baffled by a job application asking you to ”demonstrate teamwork”? It”s safe to say though that any organisation making it onto the shortlist of finalists in these Awards must be displaying teamwork
The Outstanding Contribution category of the European Supply Chain Excellence Awards is very different from all the others: you, our readers, nominate the candidates, and you vote by email for the winner (and none of those shenanigans that other less repu
As Gordon Colborn has noted in his commentary, we were slightly disappointed that, again this year, few entries went out of their way to promote the environmental, sustainability or wider Corporate Social Responsibility aspects of their submissions.
By definition, almost any finalist in these Awards (with the exception of a few purely procurement-oriented organisations) must be fairly good at ”logistics and fulfilment” – although that is by no means the total supply chain, it is certainly the core
Innovation, in the context of the Supply Chain Excellence Awards, isn”t the same thing as invention. Naturally, if an entry does offer something radically new, whether in terms of processes or technology, that would be a good recommendation for this awar
Robin Proctor, group supply chain director at Travis Perkins, says the supply chain in the buildings and construction sector is underdeveloped compared with other areas.
Bringing new drugs to market is a very expensive business: typically it can cost over €500 million and – given time limitations on patents – the pharmaceuticals company then has just 5-10 years or so to recoup its investment and make a profit for most the
It”s fair to say that, until now, most companies in the pharmaceutical and medical fields have had other things on their mind than maximising the efficiency of their supply chains. But what was once regarded as a minor cost component is coming under incr
